|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/37 | |
| A61K 38/38 | |||
| C07K 14/755 | |||
| C07K 14/76 | |||
| C12N 15/09 | |||
| C07K 14/745 | |||
| C07K 14/765 | |||
| C07K 16/18 |
| (11) | Number of the document | 2097096 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07857067.8 |
| Date of filing the European patent application | 2007-12-21 | |
| (97) | Date of publication of the European application | 2009-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2007/011356 |
| Date | 2007-12-21 |
| (87) | Number | WO 2008/077616 |
| Date | 2008-07-03 |
| (30) | Number | Date | Country code |
| 06026747 | 2006-12-22 | EP | |
| 879334 P | 2007-01-09 | US |
| (72) |
SCHULTE, Stefan, DE
WEIMER, Thomas, DE
METZNER, Hubert, DE
|
| (73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE |
| MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE |